CDK1 and familial pancreatic carcinoma: In this study, we demonstrated that AR-42 inhibited growth of pancreatic cancer cells in vitro and in vivo, and caused cell cycle G2/M arrest by regulating expression levels of cyclin B1, cyclin B2, CDK1, and p21 (Fig 1).